title: Single lung transplantation for severe chronic obstructive pulmonary disease. Washington University Lung Transplant Group.
abstract: Single lung transplantation (SLT) has been considered physiologically inappropriate for patients with chronic obstructive pulmonary disease (COPD). It has been postulated that the high static compliance and elevated pulmonary vascular resistance of the native lung functioning in parallel with the more normal allografted lung could cause unacceptable ventilation-perfusion mismatching and/or overinflation of the native lung with encroachment on the expansion of the transplanted lung. While some degree of ventilation-perfusion imbalance may be physiologically obligatory after SLT for COPD, a significant disruption in gas exchange may not occur unless a complication, such as rejection or infection, arises in the transplanted lung. A 60-year-old man with COPD who underwent successful SLT is presented and discussed. In spite of scintigraphic evidence of ventilation-perfusion mismatching between the native lung and the allograft during the first six postoperative weeks, the recipient had normal resting gas exchange on room air after the second postoperative week. Fourteen weeks after transplantation, his maximum oxygen uptake was 37.3 percent of the predicted maximal value, and no evidence of ventilatory limitation was detected. His functional status and lifestyle have been markedly improved by SLT. The role of SLT for COPD should be reconsidered. It may be a reasonable transplantation alternative for selected patients with COPD who are not candidates for double lung transplantation (DLT).
authors: Respiratory and Critical Care Division, Washington University School of Medicine, St. Louis.
authors: E P
authors: EP
authors: Trulock
authors: T M
authors: TM
authors: Egan
authors: N T
authors: NT
authors: Kouchoukos
authors: L R
authors: LR
authors: Kaiser
authors: M K
authors: MK
authors: Pasque
authors: N
authors: N
authors: Ettinger
authors: J D
authors: JD
authors: Cooper
mesh_terms: D015444:Exercise; D005080:Exercise Test; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000601:surgery*; D016040:Lung Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011659:Pulmonary Gas Exchange; D014692:Ventilation-Perfusion Ratio
chemical_list: D007166:Immunosuppressive Agents